Chemokine receptor CXCR2 mediates bacterial clearance rather than neutrophil recruitment in a murine model of pneumonic plague

American Journal of Pathology

Volumn 178, Issue 3, 2011, Pages 1190-1200

  Eisele, Nicholas A ^a,b   Lee Lewis, Hanni ^a   Besch Williford, Cynthia ^a   Brown, Charles R ^a,b   Anderson, Deborah M ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; KERATINOCYTE DERIVED CHEMOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BRONCHOPNEUMONIA; CLEARANCE; CONTROLLED STUDY; CXCR2 GENE; DISEASE COURSE; GENE; GENE LOCUS; HOST RESISTANCE; INFLAMMATION; INNATE IMMUNITY; KC GENE; LETHALITY; MOUSE; NEUTROPHIL; NONHUMAN; PLAGUE; PRIORITY JOURNAL; SEPTICEMIA; UPREGULATION;

EID: 79952741550     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2010.11.067     Document Type: Article

References (61)

1. Hamilton T, Novotny M, Datta S, Mandal P, Hartupee J, Tebo J, Li X: Chemokine and chemoattractant receptor expression: post-transcriptional regulation. J Leuk Biol 2007, 82:213-219 (Pubitemid 47230629)
2. Nasser M, Raghuwanshi S, Grant D, Venkatakrishna R, Rajarathnam K, Richardson R: Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer. J Immunol 2009, 183:3425-3432
3. Smith K, Clatworthy M: FcgRIIB in autoimmunity and infection: evolutionary and therapeutic implications. Nat Rev Immunol 2010, 10:328-343
4. Oquendo P, Alberta J, Wen D, Graycar J, Derynck R, Stiles C: The platelet-derived growth factor-inducible KC gene encodes a secretory protein related to platelet alpha-granule proteins. J Biol Chem 1989, 264:4133-4137 (Pubitemid 19072306)
5. Tekamp-Olson P, Gellegos C, Bauer D, McClain J, Sherry B, Fabre M, Van Deventer S, Cerami A: Cloning and characterization of cDNAs for murine macrophage inflammatory protein-2 and its human homologues. J Exp Med 1990, 172:911-919 (Pubitemid 20301237)
6. Zhang X, Liu Q, Wang Y, Thorlacius H: CXC chemokines. MIP-2 and KC induce P-selectin-dependent neutrophil rolling and extravascular migration in vivo. Br J Pharmacol 2001, 133:413-421 (Pubitemid 33027778)
7. Chapman R, Phillips J, Hipkin R, Curran A, Lundell D, Fine J: CXCR2 antagonists for the treatment of pulmonary disease. Phamacol Ther 2009, 121:55-68
8. Mehrad B, Strieter R, Moore T, Tsai W, Lira S, Standiford T: CXC chemokine receptor-2 ligands are necessary components of neutrophil mediated host defense in invasive pulmonary aspergillosis. J Immunol 1999, 163:6086-6094
9. Moore T, Newstead M, Strieter R, Mehrad B, Beaman B, Standiford T: Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Norcardia asteroides infection. J Immunol 2000, 164:908-915 (Pubitemid 30043717)
10. Tsai W, Strieter R, Mehrad B, Newstead M, Zeng X, Standiford T: CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia. Infect Immun 2000, 68:4289-4296 (Pubitemid 30434585)
11. Tateda K, Moore T, Newstead M, Tsai W, Zeng X, Deng J, Chen G, Reddy R, Yamaguchi K, Standiford T: Chemokine-dependent neutrophil recruitment in a murine model of Legionella pneumonia: potential role of neutrophils as immunoregulatory cells. Infect Immun 2001, 69:2017-2024 (Pubitemid 32239664)
12. Hotchkiss R, Nicholson D: Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 2006, 6:813-822 (Pubitemid 44631650)
13. Nagarkar D, Wang Q, Shim J, Zhao Y, Tsai W, Lukacs N, Sajjan U, Hershenson M: CXCR2 is required for neutrophilic airway inflammation and hyperresponsiveness in a mouse model of human Rhinovirus infection. J Immunol 2009, 183:6698-6707
14. Spehlmann M, Dann S, Hruz P, Hanson E, McCole D, Eckmann L: CXCR2-dependent mucosal neutrophil influx protects against colitis-associated diarrhea caused by an attaching/effacing lesion-forming bacterial pathogen. J Immunol 2009, 183:3332-3343
15. Herbold W, Maus R, Hahn I, Ding N, Srivastava M, Christman J, Mack M, Reutershan J, Briles D, Paton J, Winter C, Welte T, Maus U: Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to Pneumococcal lung infection. Infect Immun 2010, 78:2620-2630
16. Jacobs J, Ortiz-Lopez A, Campbell J, Gerard C, Mathis D, Benoist C: Deficiency of CXCR2, but not other chemokine receptors, attenuates autoantibody-mediated arthritis in a murine model. Arthritis Rheum 2010, 62:1921-1932
17. Mei J, Liu Y, Dai N, Favara M, Greene T, Jeyaseelan S, Poncz M, Lee J, Worthen G: CXCL5 regulates chemokine scavenging and pulmonary host defense to bacterial infection. Immunity 2010, 33:106-117
18. Ritzman A, Hughes-Hanks J, Blaho V, Wax L, Mitchell W, Brown C: KC (CXCL1)/ CXCR2 mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis. Infect Immun 2010, 78:4593-4600
19. Seki M, Kohno S, Newstead M, Zeng X, Bhan U, Lukacs N, Kunkel S, Standiford T: Critical role of IL-1 receptor-associated kinase-M in regulating chemokine-dependent deleterious inflammation in murine influenza pneumonia. J Immunol 2010, 184:1410-1418
20. Vanderbilt J, Mager E, Allen L, Sawa T, Wiener-Kronish J, Gonzalez R, Dobbs L: CXC chemokines and their receptors are expressed in Type II cells and upregulated following lung injury. Am J Respir Cell Mol Biol 2003, 29:661-668 (Pubitemid 38045934)
21. Neff T, Guo R, Neff S, Sarma J, Speyer C, Gao H, Bernacki K, Huber-Lang M, McGuire S, Hoesel L, Riedemann N, Beck-Schimmer B, Zetoune F, Ward P: Relationship of acute lung inflammatory injury to Fas/FasL system. Am J Pathol 2005, 166:685-694 (Pubitemid 40315626)
22. Schmal H, Shanley T, Jones M, Friedl H, Ward P: Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 1996, 156:1963-1972 (Pubitemid 26069332)
23. Wang Z, Rui T, Yang M, Valiyeva F, Kvietys P: Alveolar macrophages from septic mice promote polymorphonuclear leukocyte transendothelial migration via an endothelial cell Src Kinase/ NADPH oxidase pathway. J Immunol 2008, 181:8735-8744
24. Gordon J, Li F, Zhang X, Wang W, Zhao X, Nayyar A: The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals. J Leukoc Biol 2005, 78:1265-1272
25. Pollitzer R: Plague. Geneva, Switzerland, World Health Organization, 1954
26. Lathem W, Crosby S, Miller V, Goldman W: Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci U S A 2005, 102:17786-17791 (Pubitemid 41803575)
27. Anderson D, Ciletti N, Lee-Lewis H, Elli D, Segal J, Overheim K, DeBord K, Tretiakova M, Brubaker R, Schneewind O: Pneumonic plague pathogenesis and immunity in Brown Norway rats. Am J Pathol 2009, 174:910-921
28. Huang X, Nikolich M, Lindler L: Current trends in plague research: from genomics to virulence. Clin Med Res 2006, 4:189-199 (Pubitemid 44496012)
29. Montminy S, Khan N, McGrath S, Walkowicz M, Sharp F, Conlon J, Fukase K, Kusumoto S, Sweet C, Miyake K, Akira S, Cotter R, Goguen J, Lien E: Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 2006, 7:1066-1073 (Pubitemid 44420651)
30. Auerbuch V, Golenbock D, Isberg R: Innate immune recognition of Yersinia pseudotuberculosis type III secretion. PLoS Pathog 2009, 5:1000686
31. Agar S, Sha J, Foltz S, Erova T, Walberg K, Parham T, Baze W, Suarez G, Peterson J, Chopra A: Characterization of a mouse model of plague after aerosolization of Yersinia pestis CO92. Microbiology 2008, 154:1939-1948
32. Agar S, Sha J, Foltz S, Erova T, Walberg K, Baze W, Suarez G, Peterson J, Chopra A: Characterization of the rat pneumonic plague model: Infection kinetics following aerosolization of Yersinia pestis CO92. Microbes Infect 2009, 11:205-214
33. Lee-Lewis H, Anderson D: Absence of inflammation and pneumonia during infection with non-pigmented Yersinia pestis reveals new role for the pgm locus in pathogenesis. Infect Immun 2010, 78:220-230
34. 2+ response, and virulence of Yersinia pestis. J Bacteriol 1995, 177:2530-2542
35. Hill J, Leary S, Griffin K, Williamson E, Titball R: Regions of Yesinia pestis V antigen that contribute to protection against plague identified by passive and active immunization. Infect Immun 1997, 65:4476-4482 (Pubitemid 27463214)
36. Weeks S, Hill J, Friedlander A, Welkos S: Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis. Microb Path 2002, 32:227-237 (Pubitemid 34729217)
37. Fetherston J, Perry R: Yersinia pestis - etiologic agent of plague. Clin Microbiol Rev 1997, 10:35-66 (Pubitemid 27042831)
38. Cowan C, Philipovskiy A, Wulff-Strobel C, Ye Z, Straley S: Anti-LcrV antibodies inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis. Infect Immun 2005, 73:6127-6137 (Pubitemid 41193052)
39. Eisele N, Anderson D: Dual-function antibodies to Yersinia pestis LcrV required for pulmonary clearance of plague. Clin Vacc Immunol 2009, 16:1720-1727
40. Quenee L, Berube B, Segal J, Elli D, Ciletti N, Anderson D, Schneewind O: Amino acid residues 196-225 of LcrV represent a plague protective epitope. Vaccine 2010, 28:1870-1876
41. Burrows T, Jackson S: The virulence-enhancing effect of iron on nonpigmented mutants of virulent strains of Pasteurella pestis. Br J Exp Path 1956, 37:577-583
42. Brubaker R, Beesley E, Surgalla M: Pasteurella pestis: Role of Pesticin I and iron in experimental plague. Science 1965, 149:422-424
43. Fetherston J, Schuetze P, Perry R: Loss of the pigmentation phenotype in Yersinia pestis is due to the spontaneous deletion of 102kb of chromosomal DNA which is flanked by a repetitive element. Mol Microbiol 1992, 6:2693-2704
44. Pujol C, Bliska J: The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 2003, 71:5892-5899 (Pubitemid 37205642)
45. Grabenstein J, Marceau M, Pujol C, Simonet M, Bliska J: The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infect Immun 2004, 72:4973-4984 (Pubitemid 39223380)
46. Pujol C, Grabenstein J, Perry R, Bliska J: Replication of Yersinia pestis in interferon γ-activated macrophages requires ripA, a gene encoded in the pigmentation locus. Proc Natl Acad Sci U S A 2005, 102:12909-12914 (Pubitemid 41279463)
47. Noel B, Lilo S, Capurso D, Hill J, Bliska J: Yersinia pestis can bypass protective antibodies to LcrV and activation with gamma interferon to survive and induce apoptosis in murine macrophages. Clin Vaccine Immunol 2009;16:1457-1466
48. Surgalla M, Beesley E: Congo red-agar plating medium for detecting pigmentation in Pasteurella pestis. Appl Microbiol 1969, 18:834-837
49. Brown C, Blaho V, Loiacono C: Treatment of mice with the neutrophil-depleting antibody RB6-8C5 results in early development of experimental lyme arthritis via the recruitment of Gr-1 polymorphonuclear leukocyte-like cells. Infect Immun 2004, 72:4956-4965 (Pubitemid 39223378)
50. Stillie R, Stadnyk A: The functional signficance behind expressing two IL-8 receptor types on PMN. J Leuko Biol 2009, 86:529-543
51. Laws T, Davey M, Titball R, Lukaszewski R: Neutrophils are important in early control of lung infection by Yersinia pestis. Microbes Infect 2010, 12:331-335
52. Marcos V, Zhou Z, Yildirim A, Bohla A, Hector A, Vitkov L, Wiedenbauer E, Krautgartner W, Stoiber W, Belohradsky B, Rieber N, Kormann M, Koller B, Roscher A, Roos D, Griese M, Eickelberg O, Doring G, Mall M, Hartl D: CXCR2 mediates NADPH oxidase-independent neutrophil extracellular trap formation in cystic fibrosis airway inflammation. Nat Med 2010, 16:1018-1023
53. Nimmerjahn F, Ravetch J: Rcg receptors as regulators of immune responses. Nat Rev Immunol 2008, 8:34-47
54. Tian H, Weber S, Thorkildson P, Kozel T, Pirofski L: Efficacy of opsonic and nonopsonic serotype 3 Pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice. Infect Immun 2009, 77:1502-1513
55. Gondwe E, Molyneux M, Goodall M, Graham S, Mastroeni P, Drayson M, MacLennan C: Importance of antibody and complement for oxidative burst and killing of invasive nontyphoidal Salmonella by blood cells in Africans. Proc Natl Acad Sci U S A 107:3070-3075, 2010
56. Guo R, Riedemann N, Sun L, Gao H, Shi K, Reuben J, Sarma V, Zetoune F, Ward P: Divergent signaling pathways in phagocytic cells during sepsis. J Immunol 2006, c177:1306-1313 (Pubitemid 44036637)
57. Kolodziejek A, Schnider D, Rohde H, Wojtowicz A, Bohach G, Minnich S, Hovde C: Outer membrane protein X (Ail) contributes to Yersinia pestis virulence in pneumonic plague and its activity is dependent on LPS core length. Infect Immun 2010, 78:5233-5243.
58. Riddirisch D, Flierl M, Nadeau B, Day D, Huber-Lang M, Mackay C, Zetoune F, Gerard N, Cianflone K, Köhl J, Gerard C, Sarma J, Ward P: Functional roles for C5a receptors in sepsis. Nat Med 2008, 14:551-557 (Pubitemid 351655216)
59. Lien-Teh W: A Treatise on Pneumonic Plague. Geneva, Switzerland, League of Nations Health Organization, 1926
60. Lee J, Cacalano G, Camerato T, Toy K, Moore M, Wood W: Chemokine binding and activities mediated by the mouse IL-8 receptor. J Immunol 1995, 155:2158
61. Spinner JL, Cundiff JA, Kobayashi SD: Yersinia pestis type III secretion system-dependent inhibition of human polymorphonuclear leukocyte function. Infect Immun 2008, 76:3754-3760